title: Prostacyclin and risk of thromboembolism.
authors.forename: J M
authors.initials: JM
authors.lastname: Varela-Aguilar
authors.forename: M C
authors.initials: MC
authors.lastname: Sánchez-Hueso
authors.forename: M D
authors.initials: MD
authors.lastname: González-Jimenez
authors.forename: R F
authors.initials: RF
authors.lastname: García-Contreras
authors.forename: M A
authors.initials: MA
authors.lastname: González dela Puente
mesh_terms: D000818:Animals; D011464:Epoprostenol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D013923:Thromboembolism / Q000139:chemically induced*
chemical_list: D010975:Platelet Aggregation Inhibitors; D011464:Epoprostenol